MEDTEQ+

NURA Medical specializes in developing innovative medical devices aimed at enhancing patient care and improving clinical efficiency. Their primary product is a weight estimation device coupled with patient-specific dosing software, designed to streamline medication administration for pediatric patients. This technology enables hospitals and clinics to optimize staffing and deliver accurate treatment promptly.

Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes. It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay. Creative Destruction Labs supports the company.

Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.

Founded in 2014, Arbutus Medical develops and manufactures surgical power tools aimed at reducing healthcare costs. Its flagship product is a radically affordable orthopedic power tool system used in trauma centers, veterinary hospitals, military deployments, and hospitals worldwide.

LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. The company is creating experiences to assist consumers and employers all over the world in better managing anxiety and stress. They have created wellness-focused experiences that deliver benefits in as little as 5 minutes using innovative human-centered design at the intersection of art, science, and technology.

HALEO Preventive Health Solutions Inc. is a Montréal-based company founded in 2015 that specializes in tele-psychotherapy software and mobile applications focused on treating sleep and mental health disorders. The clinic offers healthcare programs designed to improve sleep quality and address insomnia through video consultations with qualified doctors, therapists, and experts. By leveraging digital solutions, HALEO aims to enhance access to high-quality care, thereby promoting better health and performance. Their services not only assist individuals in managing sleep-related issues but also help organizations mitigate costs associated with productivity losses, accidents, and employee burnout by fostering improved sleep among their workforce.

Ditch Labs is a digital health company specializing in substance addiction treatment. It combines AI-driven behavioral therapy with innovative drug delivery devices, focusing initially on nicotine addiction.

Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company specializes in quantitative ultrasound technology that supports point-of-care diagnostics and procedure guidance. Its portable devices provide a non-invasive method for diagnosing liver diseases, particularly in quantifying fatty liver disease, thereby enhancing the standard of care provided by medical practitioners. The company's mission is to facilitate routine assessment and management of liver health with reliable diagnostic accuracy.

Optina Diagnostics is a diagnostics company focusing on retinal imaging and artificial intelligence to provide non-invasive tests that detect signs of neurodegenerative and ocular diseases. By analyzing retinal images, it identifies biomarkers associated with Alzheimer's disease, as well as eye conditions like age-related macular degeneration and diabetic retinopathy, enabling clinicians to assess brain health and disease risk early. The platform aims to support timely diagnosis and treatment decisions with a simple eye exam.

Biomark Diagnostics Inc. is a Canadian oncology-focused company that specializes in developing innovative cancer diagnostic solutions aimed at enhancing patient outcomes. Established in 2014 and headquartered in Richmond, Canada, the company is dedicated to creating non-invasive technologies for the detection, monitoring, and assessment of cancer treatment. Biomark has established a collaboration with the University of Maryland School of Medicine to discover and validate its assays, particularly for early lung cancer detection and monitoring of residual tumor activity. The company leverages its extensive intellectual property portfolio in metabolomics to improve the accuracy and prediction of cancer diagnoses. With a team of experienced scientists, engineers, and medical professionals, Biomark strives to commercialize its advanced diagnostic technologies while adhering to stringent regulatory and clinical standards.

Qurcan Therapeutics is focused on developing innovative solutions for cancer treatment through advanced nanotechnology. The company is designing Manganescan®, a novel theranostic agent that serves as both an MRI contrast agent and a radio-sensitizer. This agent enhances the early detection of brain tumors by providing improved imaging capabilities, being three times more sensitive than traditional Gadolinium-based contrast agents. Manganescan® also sensitizes cancer cells, which leads to better outcomes in radiation therapy. In addition to Manganescan®, Qurcan Therapeutics is developing a drug delivery platform that aims to enhance precision medicine for solid tumors. This platform addresses challenges associated with drug release and liver accumulation seen in lipid nanoparticles, allowing for the efficient delivery of drugs, antibodies, and RNA to difficult-to-reach tumors, including those in the brain. By improving the tumor microenvironment, Qurcan Therapeutics seeks to increase therapeutic efficacy and extend patient survival rates in cancer treatment.

Montreal-based My Intelligent Machines designs biology software that combines artificial intelligence and systems biology to support early-stage drug development and personalized therapies. The company offers a software-as-a-service platform enabling augmented intelligence-driven simulations, patient stratification, and the identification of therapeutic targets and biomarkers. By leveraging big data and AI, it helps life-science teams design precise therapies and streamline research, while also applying its platform to agriculture to optimize production systems. The goal is to accelerate efficient, targeted therapies and improve outcomes across biopharma and related fields.

Ethnocare specializes in designing and manufacturing orthopedic devices aimed at enhancing mobility for individuals with amputations. Their flagship product is the Overlay, featuring an integrated pump that facilitates easy fit adjustments of residual limbs within prostheses, eliminating the need for prosthetic socks and improving overall comfort.

Innovere Medical specializes in developing wireless peripheral devices designed to enhance patient comfort during Magnetic Resonance Imaging (MRI) examinations. Their flagship product, MRI-Voicelink, facilitates clear, noiseless communication between clinicians positioned both inside and outside the MRI suite, thereby improving patient participation and reducing anxiety levels.

Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.

Aifred Health Inc. is a Montreal-based company that specializes in developing a deep-learning clinical decision support tool aimed at enhancing personalized medicine in psychiatry. Founded in 2017, Aifred Health addresses the challenges associated with the traditional trial-and-error approach to treatment selection for mental health, particularly in depression, which is a leading cause of medical impairment worldwide. The company's application software provides features such as treatment prediction, interpretability, and patient data tracking, enabling physicians to make informed decisions tailored to individual patients. By processing de-identified data, Aifred Health's AI model facilitates personalized therapeutic choices, thereby improving the likelihood of effective treatment outcomes for patients who often do not respond to initial interventions.

SeamlessMD is a developer of a digital patient engagement platform focused on improving health outcomes for patients undergoing surgery. The company addresses the challenges of traditional surgical care, which often relies on paper instructions and human memory, by utilizing design, data, and technology to enhance the patient experience. SeamlessMD's platform supports hospitals in engaging patients through remote monitoring and data collection, which helps optimize recovery processes and reduce readmission rates. By collaborating with healthcare providers, SeamlessMD aims to deliver high-quality surgical care while lowering costs, ultimately ensuring patients have a better and more informed journey through their surgical experiences.

ODS Medical Inc. is a Montreal-based medical device company established in 2015, specializing in the design and manufacture of advanced diagnostic tools for cancer detection. The company's flagship product is an exclusive Raman spectroscopy system that enables real-time identification of tissue abnormalities across various clinical settings. By integrating innovative optical probes with sophisticated software powered by machine learning algorithms, ODS Medical aims to enhance the capabilities of physicians, allowing for critical decision-making with high sensitivity, specificity, and accuracy. Through its commitment to developing and commercializing cutting-edge technology, ODS Medical strives to revolutionize the diagnostic landscape in oncology.

Ayogo Health Inc., established in 2008 and headquartered in Vancouver, Canada, specializes in developing digital health solutions that engage patients and improve adherence to treatment plans for chronic conditions. The company's core products include GoodLife, a customizable platform combining gamification, incentives, and social features, and Alternate Reality Games, which blend online and real-world elements for educational purposes. Ayogo serves clients such as insurers, healthcare providers, and pharmaceutical companies by applying behavioral psychology and social gaming principles to enhance patient outcomes. The company's collaborative approach involves meaningful engagement with patients, end-users, and clients throughout project development.

MIMOSA Diagnostics Inc. is a Toronto-based company founded in 2016 that specializes in developing innovative medical devices for tissue assessment. The company has created the MIMOSA Pro, a handheld device that utilizes near-infrared light technology to non-invasively evaluate tissue health, enabling both patients and caregivers to monitor critical health indicators. This device is particularly beneficial for diabetes patients, as it allows for real-time assessments of foot health, which is essential in preventing complications. MIMOSA Diagnostics aims to enhance clinical decision-making by providing healthcare professionals with the capability to visualize physiological biomarkers beneath the skin's surface, delivering accurate information that can lead to improved treatment outcomes, irrespective of skin color.

Imagia Cybernetics Inc. is a Montreal-based company that specializes in medical image analysis solutions aimed at cancer detection and management. The company focuses on early detection and quantification of cancer changes, which is crucial for improving patient outcomes. Imagia's Artificial Clinical Intelligence Platform delivers timely insights into primary tumors and metastasis, thereby personalizing the cancer care continuum for patients. Utilizing a unique approach called Deep Radiomics, which combines radiomics and deep learning, the platform analyzes routine clinical imaging data to identify robust biomarkers that can predict patient outcomes. By leveraging advancements in artificial intelligence and federated learning, Imagia enhances the capabilities of clinicians, enabling them to conduct predictive, diagnostic, and prescriptive analytics while maintaining data privacy.

Montreal-based My Intelligent Machines designs biology software that combines artificial intelligence and systems biology to support early-stage drug development and personalized therapies. The company offers a software-as-a-service platform enabling augmented intelligence-driven simulations, patient stratification, and the identification of therapeutic targets and biomarkers. By leveraging big data and AI, it helps life-science teams design precise therapies and streamline research, while also applying its platform to agriculture to optimize production systems. The goal is to accelerate efficient, targeted therapies and improve outcomes across biopharma and related fields.

Aifred Health Inc. is a Montreal-based company that specializes in developing a deep-learning clinical decision support tool aimed at enhancing personalized medicine in psychiatry. Founded in 2017, Aifred Health addresses the challenges associated with the traditional trial-and-error approach to treatment selection for mental health, particularly in depression, which is a leading cause of medical impairment worldwide. The company's application software provides features such as treatment prediction, interpretability, and patient data tracking, enabling physicians to make informed decisions tailored to individual patients. By processing de-identified data, Aifred Health's AI model facilitates personalized therapeutic choices, thereby improving the likelihood of effective treatment outcomes for patients who often do not respond to initial interventions.

Rna Diagnostics Inc. is a Toronto-based cancer diagnostics company established in 2010. It specializes in developing innovative medical diagnostic tools aimed at improving cancer management and patient outcomes. The company's flagship product, the RNA Disruption Assay, provides oncologists with a means to evaluate the effectiveness of chemotherapy by measuring the degree of ribosomal RNA disruption, a biomarker indicative of impending cell death. This assessment allows healthcare providers to determine whether the current cancer treatment is beneficial, thereby enabling them to avoid unnecessary side effects and consider alternative therapies that could enhance survival rates. Rna Diagnostics serves a diverse clientele, including patients, healthcare systems, and clinical research centers across Canada, Europe, and the United States, with its laboratory located in Ontario, Canada.

Saccade Analytics Inc. is a Montreal-based company that specializes in developing clinical tools for analyzing data from patients' eye and head movements during simple tasks to assess brain function. Founded in 2016 by Dr. Mimi Galiana, a pioneer in the field of eye and head movement analysis, the company aims to enhance neurological care by translating advanced research into practical applications. Its flagship product, InSight, is designed for clinicians and therapists to diagnose and monitor conditions such as concussions, vestibular disorders, and other neurological issues. By harnessing decades of research, Saccade Analytics strives to provide accessible diagnostic tools that improve patient outcomes.

Optina Diagnostics is a diagnostics company focusing on retinal imaging and artificial intelligence to provide non-invasive tests that detect signs of neurodegenerative and ocular diseases. By analyzing retinal images, it identifies biomarkers associated with Alzheimer's disease, as well as eye conditions like age-related macular degeneration and diabetic retinopathy, enabling clinicians to assess brain health and disease risk early. The platform aims to support timely diagnosis and treatment decisions with a simple eye exam.

Thorasys Thoracic Medical Systems Inc. is a Montreal-based respiratory medical device company dedicated to advancing pulmonary diagnostics. The company focuses on the development of innovative technologies for the diagnosis and monitoring of lung diseases, including asthma and chronic obstructive pulmonary disease. Utilizing a unique forced oscillation technique, Thorasys has created pulmonary function test equipment that allows healthcare professionals to accurately measure lung capacity across diverse patient populations. This technology facilitates early detection of lung diseases, thereby enhancing patient care and treatment outcomes.

Spinologics is a medical device company focused on spinal care technologies. It develops and manufactures devices and software to support spinal screening, imaging, and surgical workflows, including Scolioscreen, a phone-based screening device; Scolioscreen APP, software that works with the device to measure trunk rotation; and Cervision, a neck and cervical spine positioning tool used to reduce surgery time and improve x-ray imaging. The company also operates the Biomechanics Numerical Lab, which provides biomechanics support for medical device design and consulting services. Spinologics is positioned to translate ideas from concept to practice and serves healthcare facilities by offering orthopedic instruments, spinal implants, and disposable surgical tools to enhance patient outcomes.

Founded in 2015, MY01 specializes in developing digital medical devices for accurate real-time muscle pressure measurement. Its flagship product is designed to enhance the diagnosis of Acute Compartment Syndrome (ACS) by providing timely and precise measurements.

Spring Loaded Technology Inc. is a Canadian company that specializes in the design and development of bionic knee braces aimed at enhancing leg strength and mobility. Its flagship product, the Levitation knee brace, is recognized as the world's first compact and powerful device that assists with knee extension while alleviating pain and joint compression. The company offers a variety of knee braces tailored for diverse applications, including athletic activities such as skiing, running, and cycling, as well as for individuals dealing with knee osteoarthritis, injuries, and mobility impairments. Spring Loaded's products are engineered to improve performance, reduce fatigue, and support individuals in daily activities, including skilled trades. Established in 2012 and based in Dartmouth, Canada, the company prioritizes the intersection of research and development to create innovative solutions that enhance quality of life. Its products are available for purchase online.

Founded in 2011, Densitas Inc. specializes in developing breast imaging analytics technologies for radiology departments and healthcare systems. Its flagship product, densitasenterprise, is a web-based platform offering tools such as densitasdensity (ACR BI-RADS density scale assessments), densitasquality (image quality evaluations), and densitasrisk (breast cancer risk assessments). These solutions enable healthcare administrators to monitor performance indicators, manage workflows, ensure quality control, and support value-based care.

Aerial Technologies Inc. is a Montreal-based company that specializes in cloud-based motion analytics solutions utilizing artificial intelligence and existing wireless infrastructure. Founded in 2015, Aerial has developed the Motion Capture Plug, a WiFi Motion device that analyzes distortions in wireless signals to provide insights into motion activity in various environments such as homes, workplaces, hospitals, and hotels. This technology allows for monitoring without the use of cameras, wearables, or sensors, making it a cost-effective solution for detecting human presence and activities. Aerial serves a diverse clientele, including internet service providers, healthcare organizations, security systems integrators, and smart object manufacturers across the globe, with regional offices in the United States and Spain.